Whitepaper: Duolink® Technology – Illuminating Insight into Protein Interactions by HCS
Posted: 8 April 2014 | Sigma Aldrich
Alongside established drug target classes, innovative approaches are addressing previously undruggable target classes such as protein–protein interactions.
The new Duolink PLA® technology is an excellent tool to visualize and quantify protein interactions in fixed cells and tissues samples – not only in a single experiment but also in high-content screening applications.
This whitepaper is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- bi-monthly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Related content from this organisation
Related topics
HCS (High Content Screening), Protein-protein interactions (PPI)
